Chest chemotherapy for thymoma with pleural spread
Part of Cancer clinical trials.
This study tests giving chemotherapy directly into the chest (intrathoracic) during or after surgery to remove pleura tumors in people with thymoma or thymic cancer. It aims to see if this approach can reduce the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to have a thymoma or thymic cancer that has spread to the lining of the chest (pleura), either as a new diagnosis or a recurrence after surgery.
- If the cancer has come back, the first surgery must have removed the tumor completely, and at least 6 months must have passed before the recurrence.
- You must be in generally good health (able to handle daily activities, no major heart or lung problems).
- You must not have other active cancers or severe uncontrolled infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines surgery (burning away the tumor) with heated chemotherapy given directly into the chest to treat thymus gland tumors that have spread to the lining of the lung or chest wall. The goal is to remove the visible tumor and wash the area with heated chemo to help delay or prevent it from coming back.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
This trial studies PT-112, a new treatment, in people with thymoma or thymic carcinoma that has grown despite at least one prior platinum chemotherapy treatment. It may help shrink tumors or slow disease progression, especially when surgery is not possible.
This trial tests a shorter course of radiation therapy (hypofractionated) after surgery for people with Stage II or III thymoma or thymic cancer. The goal is to prevent the tumor from coming back.
This trial compares two minimally invasive surgery techniques (robotic vs. video-assisted) for removing early-stage thymomas. The goal is to see which approach offers better outcomes and recovery.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.